Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FDG PET-CT Kinetic Analysis in HNSCC
NCT02678884Completed
- Sponsor
- University Health Network
- Start
- Oct 2014
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial of fludeoxyglucose f 18 in head and neck squamous cell carcinoma (HNSCC), sponsored by University Health Network. Primary endpoint: Rate constant of 18F-FDG uptake in tumour and normal tissue before radiotherapy. Started Oct 2014; status: completed.
02
Drugs
fludeoxyglucose f 18
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02678884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678884.